Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Secretary of State for Business, Energy, and Industrial Strategy on the impact of the Voluntary Scheme for Branded Medicines Pricing Access on the life sciences sector.
Ministers in the Department engage regularly with their Ministerial counterparts on a range of issues, including those relating to the Voluntary Scheme for Branded Medicines Pricing Access.